Point72 Asset Management, L.P.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1603466
STAMFORD, CT
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$1,680,492 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2026CallValue
$623,540
CallShares
1,000
PutValue
$623,540
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in REGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $623,540 | 1,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $623,540 | 1,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $3,554,144 | 4,600 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $111,105,632 | 143,800 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $1,680,492 | 2,175 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $202,636,715 | 262,527 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $694,683 | 900 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $1,852,488 | 2,400 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $113,296,842 | 201,499 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $75,131,700 | 143,108 | Shares | Defined | 2025-08-14 | |
| 2024-09-30 | $2,312,728 | 2,200 | Put | Defined | 2024-11-14 | |
| 2023-09-30 | $1,157,904 | 1,407 | Shares | Defined | 2023-11-14 | |
| 2021-06-30 | $105,396,498 | 188,700 | Shares | Defined | 2021-08-16 | |
| 2020-06-30 | $33,433,252 | 53,609 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||